Stock MRK MERCK KGAA
Add to a list

ETFs Merck KGaA

Equities

MRK

DE0006599905

Pharmaceuticals

Market Closed - Xetra
Other stock markets
 16:36:26 13/03/2026 GMT 		5-day change 1st Jan Change
107.80 EUR -1.51% Intraday chart for Merck KGaA -2.13% -12.07%
03-12 MERCK KGAA : Barclays gives a Neutral rating ZD
03-09 MERCK KGAA : Goldman Sachs reiterates its Buy rating ZD

ETFs positioned on Merck KGaA

Name Varia. Jan 1. Weight AuM
LEVERAGE SHARES -3X SHORT GERMANY 40 ETP SECURITIES - EUR ETF Leverage Shares -3x Short Germany 40 ETP Securities - EUR
0.00%2.01% 1 M€
LEVERAGE SHARES 3X LONG GERMANY 40 ETP SECURITIES - EUR ETF Leverage Shares 3x Long Germany 40 ETP Securities - EUR
-18.25%2.01% 1 M€
LYXOR CORE DAX (DR) UCITS ETF - EUR ETF Lyxor Core DAX (DR) UCITS ETF - EUR
-.--%1.8% 962 M€
NOMURA NEXT FUNDS INTERNATIONAL EQUITY MSCI-KOKUSAI (YEN-HEDGED) ETF - JPY ETF Nomura NEXT FUNDS International Equity MSCI-KOKUSAI (Yen-Hedged) ETF - JPY
-3.15%0.97% 26 M€
INDEXIQ FACTORS SUSTAINABLE EUROPE EQUITY UCITS ETF - EUR ETF IndexIQ Factors Sustainable Europe Equity UCITS ETF - EUR
+0.71%0.47% 150 M€
VANGUARD INTERNATIONAL EQUITY INDEX FUNDS - VANGUARD FTSE ALL-WORLD EX-US ETF ETF Vanguard International Equity Index Funds - Vanguard FTSE All-World ex-US ETF
-2.46%0.09% 33,076 M€
DAY HAGAN/NED DAVIS RESEARCH SMART SECTOR INTERNATIONAL ETF - USD ETF Day Hagan/Ned Davis Research Smart Sector International ETF - USD
-0.26%0.09% 32 M€
12

Company Profile

Logo Merck KGaA
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (42.6%); - pharmaceutical products (40.8%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (16.6%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Switzerland (1.9%), Europe (23.7%), the United States (24.8%), North America (1.3%), China (13.7%), Asia/Pacific (19.2%), Latin America (6.9%), Middle East and Africa (3.7%).
Employees
59,077
Sector
Pharmaceuticals
Calendar
04-27 - Ex-dividend date - 2.2 EUR
More about the company

Income Statement and Estimates

More financial data

Ratings

Trader

Trader

This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.

Investor

Investor

This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.

Global

Global

This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quality

Quality

This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

ESG MSCI

ESG MSCI

The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

AAA
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
107.80EUR
Average target price
147.12EUR
Spread / Average Target
+36.48%
Consensus
EPS Estimates
Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. MRK Stock
  4. ETFs Merck KGaA
SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

MarketScreener -
United-States
MarketScreener Canada -
Canada

MIDDLE EAST

MarketScreener Saudi Arabia -
Saudi Arabia
MarketScreener UAE Emirates -
United Arab Emirates

EUROPE

Zonebourse -
France
MarketScreener Deutschland -
Deutschland
Zonebourse Suisse -
Suisse
MarketScreener Schweiz -
Schweiz
MarketScreener Italia -
Italia
MarketScreener Österreich -
Österreich
MarketScreener België -
België
MarketScreener Nederland -
Nederland
MarketScreener España -
España
MarketScreener Sverige -
Sverige
MarketScreener UK -
United Kingdom

APAC

MarketScreener Australia -
Australia
MarketScreener India -
India
MarketScreener Hong Kong -
Hong Kong
United States

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition